Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Cougoul, Pierre
THRIVE-131, NCT04935879: A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises	Completed	3	243	Europe, US, RoW	Inclacumab, Placebo	Pfizer	Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis	06/24	06/24
HBOT-SCD, NCT05289700: Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD)	Recruiting	3	100	Europe	HBOT in Hyperbaric chamber, Hyperbaric Oxygen Therapy, Hyperbaric chamber for placebo, Placebo Comparator	University Hospital, Geneva, University Hospital, Toulouse, Hospices Civils de Lyon	Sickle Cell Disease, Hyperbaric Oxygen Therapy, Vaso-occlusive Crisis	09/24	03/25
STIREX, NCT06769139: Evaluation of the Impact of Red Blood Cell Exchange on Thrombo-inflammation in Sickle Cell Disease	Not yet recruiting	N/A	20	Europe	Red blood cell exchange	University Hospital, Toulouse, Etablissement Français du Sang	Sickle Cell Disease	12/25	01/26
ESCORT-HU Extension, NCT04707235: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study	Active, not recruiting	N/A	2093	Europe, RoW	Hydroxycarbamide, Siklos, Hydroxyurea	Theravia, International Clinical Trials Association	Sickle Cell Disease	08/25	08/25
Il-Padre, NCT05646888: Inflammation, Platelets and Sickle Cell Disease	Recruiting	N/A	25	Europe	Blood sampling	University Hospital, Toulouse	Platelet Activation, Thromboinflammation, Sickle Cell Disease	11/25	12/25